ClinicalTrials.Veeva

Menu

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

University of Aarhus logo

University of Aarhus

Status and phase

Completed
Phase 2

Conditions

Neoplasms, Second Primary
Head and Neck Neoplasms
Recurrence

Treatments

Procedure: Radiotherapy

Study type

Interventional

Funder types

Other
NETWORK

Identifiers

NCT00400426
DAHANCA 20

Details and patient eligibility

About

Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Incurable primary or second primary head and neck cancer
  • Speaks and reads Danish
  • Capable of filling out questionnaires for at leas two months after radiotherapy
  • Age>=18 years
  • Expected survival> 3months

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems